Duke Cancer Center /ID# 217641

Durham, North Carolina 27710-3000

0 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumors, Cancer, Metastatic Solid Tumors, Non-small-cell-lung-cancer (NSCLC), Triple-Negative Breast Cancer (TNBC)

Studies at this site

• A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors — Running, not enrolling